PANX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.885600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.910800E-01
Normal-vs-Stage2
4.172400E-01
Normal-vs-Stage3
8.467600E-01
Normal-vs-Stage4
2.023200E-01
Stage1-vs-Stage2
1.524770E-01
Stage1-vs-Stage3
6.031200E-01
Stage1-vs-Stage4
1.518050E-01
Stage2-vs-Stage3
5.014000E-01
Stage2-vs-Stage4
3.998200E-02
Stage3-vs-Stage4
1.908570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.145800E-01
Normal-vs-AfricanAmerican
3.024400E-01
Normal-vs-Asian
7.573000E-01
Caucasian-vs-AfricanAmerican
5.634400E-01
Caucasian-vs-Asian
5.015600E-01
AfricanAmerican-vs-Asian
3.107600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.731200E-01
Normal-vs-Female
3.967000E-01
Male-vs-Female
2.859000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.945200E-01
Normal-vs-Age(41-60Yrs)
1.938760E-01
Normal-vs-Age(61-80Yrs)
6.684400E-01
Normal-vs-Age(81-100Yrs)
6.553600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.140780E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.638800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.343000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.324020E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.137600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.169600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.980600E-01
Normal-vs-Daily Drinker
8.570000E-01
Normal-vs-Weekly Drinker
4.401200E-01
Normal-vs-Occasional Drinker
4.821000E-01
Normal-vs-Social Drinker
4.397000E-01
Non Drinker-vs-Daily Drinker
5.768600E-01
Non Drinker-vs-Weekly Drinker
4.525200E-01
Non Drinker-vs-Occasional Drinker
5.084800E-01
Non Drinker-vs-Social Drinker
3.080200E-01
Daily Drinker-vs-Weekly Drinker
1.975420E-01
Daily Drinker-vs-Occasional Drinker
2.294600E-01
Daily Drinker-vs-Social Drinker
1.399950E-01
Weekly Drinker-vs-Occasional Drinker
8.977200E-01
Weekly Drinker-vs-Social Drinker
7.946600E-01
Occasional Drinker-vs-Social Drinker
6.916400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.923200E-01
Normal-vs-Grade 2
7.945000E-01
Normal-vs-Grade 3
3.967000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.784100E-04
Grade 1-vs-Grade 3
3.578900E-04
Grade 1-vs-Grade 4
7.923200E-01
Grade 2-vs-Grade 3
2.479400E-01
Grade 2-vs-Grade 4
7.945000E-01
Grade 3-vs-Grade 4
3.967000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.877400E-01
Normal-vs-NonDiabetic
4.949800E-01
Diabetic-vs-NonDiabetic
3.595200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.149600E-01
Normal-vs-NoPancreatitis
5.378600E-01
Pancreatitis-vs-NoPancreatitis
3.923800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.498600E-01
Normal-vs-N1
3.999400E-01
N0-vs-N1
2.495000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.175600E-01
Normal-vs-TP53-NonMutant
7.978800E-01
TP53-Mutant-vs-TP53-NonMutant
2.38160000000098E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
